A pilot study of the modified Atkins diet for Sturge-Weber syndrome

Eric H Kossoff1, Jennifer L Borsage, Anne M Comi

  • 1The John M. Freeman Pediatric Epilepsy Center, Department of Neurology, Johns Hopkins Medical Institutions, Baltimore, MD, USA. ekossoff@jhmi.edu

Epilepsy Research
|October 12, 2010
PubMed

Insights

The modified Atkins diet (MAD) effectively reduced seizures in children with Sturge-Weber syndrome (SWS). This epilepsy diet is a promising, safer alternative for managing intractable seizures in this population.

Area of Science:

  • Neurology
  • Dietary Therapies
  • Pediatric Epilepsy

Background:

  • Sturge-Weber syndrome (SWS) is a rare neurological disorder often associated with intractable epilepsy.
  • Traditional ketogenic diets, while effective, can be challenging due to fluid and calorie restrictions.
  • The modified Atkins diet (MAD) offers a less restrictive alternative for epilepsy management.

Purpose of the Study:

  • To evaluate the efficacy and safety of the modified Atkins diet (MAD) as a treatment for intractable seizures in children with Sturge-Weber syndrome (SWS).

Main Methods:

  • A prospective study involving five children aged 4-18 years with SWS and frequent intractable seizures.
  • Participants were initiated on the modified Atkins diet (MAD) for a 6-month period.
  • Assessment included monitoring for urinary ketosis and seizure frequency.

Main Results:

  • All five children achieved urinary ketosis while on the MAD.
  • Significant seizure improvement was observed in all participants.
  • Three out of five children experienced a greater than 50% reduction in seizure frequency.

Conclusions:

  • The modified Atkins diet (MAD) is a feasible and effective dietary therapy for reducing intractable seizures in children with Sturge-Weber syndrome (SWS).
  • The MAD demonstrates potential as a safer alternative to the ketogenic diet for this pediatric population due to its less restrictive nature.